相关实验视频
Updated: Jun 22, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
545
菲内伦:谁应该为CKD开处方? 医生协会的观点 医生协会的观点
1Department of Nephrology, Mayo Clinic College of Medicine, Rochester, MN, USA. ness.becky@mayo.edu.
Journal of nephrology
|July 3, 2024
概括
医生助理 (PA) 在管理糖尿病病 (DKD) 和CKD方面至关重要. 通过使用fineerenone处方和监测策略来赋予PA权力,可以改善患者的治疗结果并预防功能衰竭.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
背景情况:
- 糖尿病病 (DKD) 影响30%-40%的糖尿病患者,在慢性病 (CKD) 中显著增加心血管风险.
- 尽管有诸如芬瑞龙 (finerenone) 等可用的治疗方法和尿蛋白与肌素比率 (UACR) 等查工具,但DKD患者的护理需要增强资源.
- 医生助理 (PA) 是多学科DKD护理团队的组成部分,参与诊断,监测和管理.
研究的目的:
- 突出医生助理在治疗糖尿病病中的关键作用.
- 强调需要授权PA在处方先进疗法,如finerenone.
- 通过加强PA参与初级保健来探索改善DKD护理的策略.
主要方法:
- 关于糖尿病病管理和先进实践提供者的作用的当前文献的综述.
- 在2型糖尿病患者中分析芬瑞的疗效和治疗CKD的位置.
- 讨论PAs在监测功能,风险因素和患者自我管理方面的责任.
主要成果:
- 费内伦是一种非类固醇矿物质皮质类受体对抗剂,是减少DKD脏和心血管风险的关键治疗方法.
- 消化剂积极监测功能 (血清肌素,UACR) 和心血管风险因素,鼓励患者自我照顾.
- 初级保健医疗机构比专家更少地开处方,这表明利用率存在差距,需要加强授权.
结论:
- 在初级保健中赋予医生助理知识和处方权力,对像finerenone这样的药物进行授权,可以优化DKD管理.
- 在监测和患者咨询中增强PA的作用对于早期发现和预防功能衰竭和心血管事件至关重要.
- 通过多学科指导方针解决患者参与和复杂的转诊系统等障碍是必要的,以改善DKD护理.
相关概念视频
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:15Renal Drug Excretion: Overview
144
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
144
01:06Renal Drug Clearance: Overview
180
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
180
01:17Factors Affecting Renal Clearance: Renal Impairment
74
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
74
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
208
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
208